A Randomized, Open-label, Multiple-dose, Partial Crossover Study to Explore the Pharmacokinetics and the Pharmacodynamics of YH4808 New Formulation in Healthy Subjects

Trial Profile

A Randomized, Open-label, Multiple-dose, Partial Crossover Study to Explore the Pharmacokinetics and the Pharmacodynamics of YH4808 New Formulation in Healthy Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs YH 4808 (Primary)
  • Indications Gastro-oesophageal reflux; NSAID-induced ulcer; Reflux oesophagitis
  • Focus Pharmacokinetics
  • Sponsors Yuhan
  • Most Recent Events

    • 17 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Aug 2014 The study protocol has been amended to exclude YH4808 New Formulation 600mg arm.
    • 21 Aug 2014 Planned number of patients changed from 50 to 80 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top